The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Carmell Therapeutics - Biotechnology Company Focuses on Development and Commercialization of Plasma-based Bioactive Materials

SNNLive spoke with Randy Hubbell, President & CEO of Carmell Therapeutics Corporation, a private company, at the BIO CEO & Investor Conference 2019 in New York, NY.

Share With

Tuesday, March 12, 2019

   

© 2019 Stock News Now